comparemela.com

Latest Breaking News On - Adcentrx therapeutics - Page 1 : comparemela.com

Adcentrx Therapeutics Announces China NMPA Grants IND Clearance for ADRX-0706, a Novel Nectin-4 ADC for the Treatment of Advanced Solid Tumors

/PRNewswire/ Adcentrx Therapeutics ("Adcentrx"), a biotechnology company revolutionizing Antibody-Drug Conjugate (ADC) therapeutics for cancer and other.

Hui liChina national medical products administrationAntibody drug conjugateInvestigational new drugChief executive officerAdcentrx therapeutics

Adcentrx Therapeutics Appoints Meng Jiang as Chief Financial Officer

/PRNewswire/ Adcentrx Therapeutics ("Adcentrx"), a biotechnology company revolutionizing Antibody-Drug Conjugate (ADC) therapeutics for cancer and other.

Meng jiangNew yorkUnited statesHui liFu weiWellesley collegeBusiness development asiaInvestment bankManagement committee memberAdcentrx therapeuticsAntibody drug conjugateChief financial officerSenior managing directorManagement committeeFar east horizonChief executive officer

Adcentrx Therapeutics to Present Preclinical Data for Nectin-4 ADC Program at the American Association for Cancer Research (AACR) Annual Meeting 2024

/PRNewswire/ Adcentrx Therapeutics ("Adcentrx"), a biotechnology company revolutionizing Antibody-Drug Conjugate (ADC) therapeutics for cancer and other.

United statesSan diegoAmerican association for cancer researchAntibody drug conjugateAmerican associationCancer researchAnnual meetingAntibody drug conjugatesAdcentrx therapeutics

Investors got more clues that rate cuts are imminent

Christmas is fast approaching and the atmosphere on stock markets is rather joyful, with most indices in the green. Investors are cheering fresh data showing a slowdown in eurozone inflation in. -December 19, 2023 at 09:30 am EST - MarketScreener

United statesNew south walesRed seaDjibouti generalSouth koreaSan franciscoUnited kingdomHong kongCity ofWhite houseDistrict of columbiaHunter bidenSea brentAustan goolsbeeKronos bioRaphael bostic

Adcentrx Extends Series A+ Financing to $51M

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

San diegoUnited statesHui liAdcentrx therapeuticsAntibody drug conjugateQuan capital

vimarsana © 2020. All Rights Reserved.